Moon, J. S. (2019). Letter: Dipeptidyl Peptidase-4 Inhibitors versus Other Antidiabetic Drugs Added to Metformin Monotherapy in Diabetic Retinopathy Progression: A Real World-Based Cohort Study (Diabetes Metab J 2019;43:640–8). Diabetes Metab J.
Citação norma ChicagoMoon, Jun Sung. "Letter: Dipeptidyl Peptidase-4 Inhibitors Versus Other Antidiabetic Drugs Added to Metformin Monotherapy in Diabetic Retinopathy Progression: A Real World-Based Cohort Study (Diabetes Metab J 2019;43:640–8)." Diabetes Metab J 2019.
Citação norma MLAMoon, Jun Sung. "Letter: Dipeptidyl Peptidase-4 Inhibitors Versus Other Antidiabetic Drugs Added to Metformin Monotherapy in Diabetic Retinopathy Progression: A Real World-Based Cohort Study (Diabetes Metab J 2019;43:640–8)." Diabetes Metab J 2019.